Facebook | The Stute16h
FDA approves first-of-its-kind non-opioid pain medication
On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...
JD Supra1d
FDA Approved Journavx, a Non-Opioid Drug for Pain Management
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
'There has never been a more dangerous time to take drugs': The rising global threat of nitazenes and synthetic opioids
In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...
BMJ15d
Does pain optimisation impact delirium outcomes in critically ill patients? A systematic review and meta-analysis protocol
Side effects of some analgesic medications include dysphoria, hallucinations and delirium. Therefore, both untreated pain and analgesic medications may be risk factors for delirium. Delirium is ...
The Hill22d
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...
The New York Times25d
In China, Government Data on Drugs Blocked From Public After Backlash
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...
The New York Times27d
In China, Rare Dissent Over a Program to Save on Drug Costs
But this year, foreign-branded drugs were largely absent from the government list of medicines that are covered under China’s national health insurance and offered at public hospitals.
Indiatimes28d
MPSC Maharashtra Food & Drugs Administrative Services Main Examination 2023 general merit list released, check direct link here
The Maharashtra Public Service Commission (MPSC) has published the general merit list for candidates who have qualified the Maharashtra Food & Drugs Administrative Services Main Examination 2023.
Medical Xpress29d
Racial disparities in opioid prescriptions persist despite socioeconomic factors
Non-white communities had significantly less access to opioid medications commonly prescribed ... This inadequate access to opioid analgesics in majority non-white communities may delay treatment ...
Scientists pinpoint FIVE common medications that could raise dementia risk by up to 125%
In an analysis of health data from 130million people, British researchers found medications which could potentially increase, or decrease, the risk that someone could be diagnosed with dementia.
Frontiers1mon
Editorial: Preclinical animal models and measures of pain: improving predictive validity for analgesic drug development - volume II
Despite the urgent need for better treatments, the development of new analgesic drugs has progressed slowly, with many promising candidates failing in clinical trials (1–4). A major reason for this ...
Canada1mon
Consultation on the draft Critical and Vulnerable Drug List
In June 2024, Health Canada committed to publishing a list of drugs that are critical to patients and vulnerable to shortages. The list will help drug shortage stakeholders focus their actions and ...